| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $131.4M | +181.4% |
| R&D Expense | $315.0M | +74.6% |
| SG&A Expense | $79.6M | +29.2% |
| Operating Income | -$263.2M | -34.8% |
| Interest Expense | $0 | -100.0% |
| Pre-tax Income | -$251.0M | -36.3% |
| Income Tax | $20.9M | — |
| Net Income | -$282.5M | -47.9% |
| EPS (Basic) | -$5.31 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $81.3M | -24.9% |
| Short-term Investments | $1.12B | -19.4% |
| Accounts Receivable | $1.0M | -93.3% |
| Current Assets | $1.24B | -20.1% |
| Total Assets | $1.27B | -19.8% |
| Current Liabilities | $295.1M | +12.8% |
| Long-term Debt | $1.0M | +0.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$273.5M | -148.9% |
| Capital Expenditures | $6.8M | +44.7% |
| Investing Cash Flow | $242.8M | +118.5% |
| Financing Cash Flow | $4.7M | -98.3% |
| Free Cash Flow | -$280.3M | -150.5% |
| -39.0% |
| EPS (Diluted) | -$5.31 | -39.0% |
| Total Liabilities |
| $703.9M |
| -12.0% |
| Stockholders' Equity | $564.9M | -27.7% |